Literature DB >> 17420400

The impact of neuropathic pain on health-related quality of life: review and implications.

Mark P Jensen1, Marci J Chodroff, Robert H Dworkin.   

Abstract

A number of high-quality studies have recently been published that examine the association between neuropathic pain and health-related quality of life (HRQoL). The current review identified 52 such studies in patients with six neuropathic pain conditions associated with lesions of either the peripheral (postsurgical neuropathic pain associated with breast and amputation surgery, postherpetic neuralgia, and painful diabetic neuropathy) or central (poststroke pain, spinal cord injury pain, multiple sclerosis pain) nervous system. The results provide strong evidence that the presence and severity of neuropathic pain are associated with greater impairments in a number of important HRQoL domains. However, the evidence also indicates that this impact varies somewhat as a function of the HRQoL domain being considered and that different measures of HRQoL are differentially sensitive to the effects of neuropathic pain. The findings have important implications for the selection of HRQoL domains and measures to use in clinical trials and in clinical research on HRQoL in persons with neuropathic pain and suggest that a biopsychosocial (as opposed to a primarily biomedical) approach would be appropriate for understanding and treating neuropathic pain.

Entities:  

Mesh:

Year:  2007        PMID: 17420400     DOI: 10.1212/01.wnl.0000259085.61898.9e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  158 in total

1.  Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.

Authors:  Molly S Crowe; Emma Leishman; Matthew L Banks; Ramesh Gujjar; Anu Mahadevan; Heather B Bradshaw; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

Review 2.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 3.  Phenotyping and genotyping neuropathic pain.

Authors:  Inna Belfer; Feng Dai
Journal:  Curr Pain Headache Rep       Date:  2010-06

4.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

5.  Chronic Orofacial Pain: Burning Mouth Syndrome and Other Neuropathic Disorders.

Authors:  Raymond C Tait; McKenzie Ferguson; Christopher M Herndon
Journal:  J Pain Manag Med       Date:  2017-01-30

6.  Central neuropathic pain after cerebral venous thrombosis is not so uncommon: an observational study.

Authors:  Jean-Marc Bugnicourt; Pierre-Yves Garcia; Sandrine Canaple; Chantal Lamy; Olivier Godefroy
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

7.  Neuropathic Pain after Shoulder Arthroplasty: Prevalence, Impact on Physical and Mental Function, and Demographic Determinants.

Authors:  Helen Razmjou; Linda J Woodhouse; Richard Holtby
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

8.  Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury.

Authors:  G J Norman; K Karelina; N Zhang; J C Walton; J S Morris; A C Devries
Journal:  Mol Psychiatry       Date:  2009-09-22       Impact factor: 15.992

9.  Patients' perspectives on pain.

Authors:  Cecilia Norrbrink; Monika Löfgren; Judith P Hunter; Jaqueline Ellis
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

10.  Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy.

Authors:  Angela Starkweather
Journal:  Pain Manag Nurs       Date:  2010-12-30       Impact factor: 1.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.